Dabrafenib effects and efficacy
Dabrafenib(Dabrafenib) is a kinase inhibitor indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma in whom the FDAapproved test has detected the BRAF V600E mutation. Dabrafenibis indicated for use in combination with trimetinib for the treatment of patients with unresectable or metastatic melanoma who have BRAF V600E or V600K mutations detected in an FDAapproved test. 2.Adjuvant therapy for patients with BRAF V600E or V600K mutated melanoma based on FDAapproved testing and with lymph node involvement after complete resection. 3. Treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose BRAF V600E mutation has been detected in an FDAapproved test. 4.Treatment of patients with locally advanced or metastatic anaplastic thyroid cancer(ATC)with BRAF V600E mutation and no satisfactory locoregional treatment options. 5.Treatment of adult and pediatric patients 1 years and 1years older with unresectable or metastatic BRAF V600E mutant solid tumors who have progressed after prior therapy and for whom no satisfactory alternative treatment options are available. 6. Treatment of pediatric patients 1 year and older with BRAF V600Emutated low-grade glioma(LGG) requiring systemic therapy.

Dabrafenibis an inhibitor of some mutant forms of BRAFkinase, targeting BRAF V600E, BRAF V600K and BRAF V600DThe in vitro IC50 values u200bu200bof the enzyme were 0.65, 0.5 and 1.84 nM respectively. Dabrafenib also inhibits wild-type BRAF and CRAF kinases with IC50 values of 3.2 and 5.0 respectively nM, as well as other kinases such as SIK1, NEK11 and LIMK1 at high concentrations. Some mutations in the BRAF gene, including those leading to BRAF V600E, can lead to constitutively activated BRAF kinase, thereby stimulating tumor cell growth. Dabrafenibinhibits cell growth in various BRAF V600 mutation-positive tumors in vitro and in vivo. If you want to get more high-quality information, you can contact Yaode. Yade will do its best to learn more about high-quality overseas drugs for you.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)